ArticleFrontiers in immunology2022

Case Report: Two Cases of Soft-Tissue Sarcomas: High TMB as a Potential Predictive Biomarker for Anlotinib Combined With Toripalimab Therapy.

Yong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.